A Purdue University-led research team has figured out how to disable a part of the SARS virus responsible for hiding it from the immune system; a critical step in developing a vaccine against the deadly disease.
The findings also have potential applications in the creation of vaccines against other coronaviruses, including MERS, said Andrew Mesecar, who led the research.
“This is a first step toward creating a weakened and safe virus for use in an attenuated live vaccine,” said Mesecar, Purdue’s Walther Professor of Cancer Structural Biology and professor of biological sciences and chemistry. “This also could serve as a molecular roadmap for performing similar studies on other coronaviruses, like MERS, because this enzyme appears to be common to all viruses within this family.”
Read more . . .
The Latest on: SARS MERS vaccine
[google_news title=”” keyword=”SARS MERS vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: SARS MERS vaccine
- SARS-CoV-2 vaccine does not increase new-onset seizure riskon April 30, 2024 at 10:10 am
There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus placebo, according to a review published online ...
- New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warnson April 29, 2024 at 10:43 pm
Study on the bioRxiv server reports that the SARS-CoV-2 KP.2 variant, despite lower infectivity, shows significant immune resistance and higher transmissibility compared to other variants, potentially ...
- Updated vaccine provides strong immune response against previous and emerging SARS-CoV-2 variantson April 29, 2024 at 8:48 pm
New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.
- The WHO updates its terminology for pathogens that transmit through the airon April 25, 2024 at 6:48 pm
The World Health Organization published a consensus statement on airborne pathogens, finally aligning the WHO with scientists who presented evidence of this early in the course of the COVID-19 ...
- Reducing risks from respiratory pathogens at the 2024 Hajjon April 23, 2024 at 5:19 pm
Mass gatherings can attract several million people from across the world and pose huge public health challenges for the host country.1 The Hajj is one of the world's largest annual religious events, ...
- The worst epidemics over the past 100 yearson April 22, 2024 at 3:18 pm
MERS cost the lives of about 500 people. SARS was discovered in 2003 as a strongly contagious ... but in 2014, cases of wild (not-vaccine-induced) polio occurred in Afghanistan and Pakistan. The WHO ...
- Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19on April 22, 2024 at 4:52 am
TrialSite News features a paper published today in Viruses (Basel), authored by an international team of researchers, including two fellows of their nations' academies of sciences (Colleen Aldous, ...
- The pandemic cost 7 million lives, but talks to prevent a repeat stallon April 21, 2024 at 7:00 pm
The main sticking point involves access to vital information about new threats that may emerge - and to the vaccines and medicines that could contain that threat.
- Arbidol Hydrochloride Market Outlook, Size, Prominent Players, Share, Revenue, and Forecast 2024 to 2032on April 18, 2024 at 9:54 pm
Arbidol Hydrochloride Market is valued approximately at USD $ billion in 2019 and is anticipated to grow with a healthy growth rate of more than $ over the forecast period 2020-2026. Arbidol ...
- Curevac gets grant for composition for covid-19 mRNA vaccine in lipid nanoparticleon April 17, 2024 at 5:34 am
Discover Curevac NV's groundbreaking patent for a composition targeting SARS-CoV-2 with mRNA and lipid nanoparticles. Learn about stabilizing mutations and substitutions in the spike protein sequence ...
via Bing News
